Skip to Content

Bioiasis AD BIOA

Morningstar Rating
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

BIOA is trading at a 623% premium.
Price
BGN 16.03
Fair Value
BGN 49.67
Uncertainty
Extreme
1-Star Price
BGN 65.66
5-Star Price
BGN 4.87
Economic Moat
Vntrw
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if BIOA is a good fit for your portfolio.

Trading Information

Previous Close Price
Day Range
52-Week Range
Bid/Ask
/
Market Cap
Volume/Avg
/

Key Statistics

Price/Earnings (Normalized)
Price/Sales
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Bioiasis AD provides specialized medical devices, equipment, and consultation services to state and private hospitals and trading companies. The company also deals in Interventional Cardiology and General Surgery consumables.
Sector
Healthcare
Industry
Medical Devices
Stock Style Box
Small Value
Total Number of Employees
1

Valuation

Metric
BIOA
Price/Earnings (Normalized)
Price/Book Value
96.58
Price/Sales
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
BIOA
Quick Ratio
1.18
Current Ratio
1.18
Interest Coverage
Quick Ratio
BIOA

Profitability

Metric
BIOA
Return on Assets (Normalized)
−4.60%
Return on Equity (Normalized)
−66.88%
Return on Invested Capital (Normalized)
−4.83%
Return on Assets
BIOA
See how this stock stacks up to its competitors with Morningstar Investor

Medical Devices Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
ABT
Abbott LaboratoriesLccfyvksGqzds$182.6 Bil
SYK
Stryker CorpCxxhmhbcmGxfm$125.9 Bil
MDT
Medtronic PLCVvmrvyxHgtcgnk$108.3 Bil
BSX
Boston Scientific CorpNmvqbwkjSmlsgm$106.9 Bil
EW
Edwards Lifesciences CorpZsmlvpbyjYgrsryj$52.3 Bil
DXCM
DexCom IncCjcwyzkcsyGvqg$50.3 Bil
ZBH
Zimmer Biomet Holdings IncDcjsbyhdfnWpnx$25.0 Bil
PHG
Koninklijke Philips NV ADRLpbmnjggFpgflg$24.3 Bil
ALGN
Align Technology IncYyhlsgzXxqlxrw$21.1 Bil
PODD
Insulet CorpNtzjxxyjsCrbfqkb$12.4 Bil

Sponsor Center